rs1554560384
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PM2
The NM_000722.4(CACNA2D1):c.95+1G>A variant causes a splice donor, intron change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000722.4 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA2D1 | ENST00000356860.8 | c.95+1G>A | splice_donor_variant, intron_variant | Intron 1 of 38 | 1 | NM_000722.4 | ENSP00000349320.3 | |||
CACNA2D1 | ENST00000423588.1 | c.95+1G>A | splice_donor_variant, intron_variant | Intron 1 of 10 | 1 | ENSP00000405395.1 | ||||
CACNA2D1 | ENST00000443883.2 | c.95+1G>A | splice_donor_variant, intron_variant | Intron 1 of 38 | 5 | ENSP00000409374.2 | ||||
CACNA2D1 | ENST00000705962.1 | c.11+1G>A | splice_donor_variant, intron_variant | Intron 1 of 37 | ENSP00000516190.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1448908Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 720770
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Brugada syndrome Uncertain:1
In summary, this variant has uncertain impact on CACNA2D1 function. The available evidence is currently insufficient to determine its role in disease. Therefore, it has been classified as a Variant of Uncertain Significance. The current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in CACNA2D1 cause disease. This sequence change affects a donor splice site in intron 1 of the CACNA2D1 gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with a CACNA2D1-related disease. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at